New Results
Pharmacological inhibition of soluble epoxide hydrolase as a new therapy for Alzheimer’s Disease
Christian Griñán-Ferré, Sandra Codony, Eugènia Pujol, Jun Yang, Rosana Leiva, Carmen Escolano, Dolors Puigoriol-Illamola, Júlia Companys-Alemany, Rubén Corpas, Coral Sanfeliu, M. Isabel Loza, José Brea, Christophe Morisseau, Bruce D. Hammock, Santiago Vázquez, Mercè Pallàs, Carles Galdeano
doi: https://doi.org/10.1101/605055
Christian Griñán-Ferré
1Pharmacology Section. Department of Pharmacology, Toxicology and Medicinal Chemistry, Faculty of Pharmacy and Food Sciences, and Institut de Neurociències, University of Barcelona, Av. Joan XXIII, 27-31, E-08028 Barcelona, Spain
Sandra Codony
2Laboratori de Química Farmacèutica (Unitat Associada al CSIC), Department de Farmacologia, Toxicologia i Química Terapèutica, Facultat de Farmàcia i Ciències de l’Alimentació, and Institute of Biomedicine (IBUB), Universitat de Barcelona, Av. Joan XXIII, 27-31, E-08028 Barcelona, Spain
Eugènia Pujol
2Laboratori de Química Farmacèutica (Unitat Associada al CSIC), Department de Farmacologia, Toxicologia i Química Terapèutica, Facultat de Farmàcia i Ciències de l’Alimentació, and Institute of Biomedicine (IBUB), Universitat de Barcelona, Av. Joan XXIII, 27-31, E-08028 Barcelona, Spain
Jun Yang
3Department of Entomology and Nematology and Comprehensive Cancer Center, University of California, Davis, California, USA
Rosana Leiva
2Laboratori de Química Farmacèutica (Unitat Associada al CSIC), Department de Farmacologia, Toxicologia i Química Terapèutica, Facultat de Farmàcia i Ciències de l’Alimentació, and Institute of Biomedicine (IBUB), Universitat de Barcelona, Av. Joan XXIII, 27-31, E-08028 Barcelona, Spain
Carmen Escolano
2Laboratori de Química Farmacèutica (Unitat Associada al CSIC), Department de Farmacologia, Toxicologia i Química Terapèutica, Facultat de Farmàcia i Ciències de l’Alimentació, and Institute of Biomedicine (IBUB), Universitat de Barcelona, Av. Joan XXIII, 27-31, E-08028 Barcelona, Spain
Dolors Puigoriol-Illamola
1Pharmacology Section. Department of Pharmacology, Toxicology and Medicinal Chemistry, Faculty of Pharmacy and Food Sciences, and Institut de Neurociències, University of Barcelona, Av. Joan XXIII, 27-31, E-08028 Barcelona, Spain
Júlia Companys-Alemany
1Pharmacology Section. Department of Pharmacology, Toxicology and Medicinal Chemistry, Faculty of Pharmacy and Food Sciences, and Institut de Neurociències, University of Barcelona, Av. Joan XXIII, 27-31, E-08028 Barcelona, Spain
Rubén Corpas
4Institute of Biomedical Research of Barcelona (IBB), CSIC and IDIBAPS, Barcelona, Spain
5CIBER Epidemiology and Public Health (CIBERESP), Madrid, Spain
Coral Sanfeliu
4Institute of Biomedical Research of Barcelona (IBB), CSIC and IDIBAPS, Barcelona, Spain
5CIBER Epidemiology and Public Health (CIBERESP), Madrid, Spain
M. Isabel Loza
6Innopharma screening platform. Biofarma research group. Centro de Investigación en Medicina Molecular y Enfermedades Crónicas (CIMUS). Universidad de Santiago de Compostela. Spain
José Brea
6Innopharma screening platform. Biofarma research group. Centro de Investigación en Medicina Molecular y Enfermedades Crónicas (CIMUS). Universidad de Santiago de Compostela. Spain
Christophe Morisseau
3Department of Entomology and Nematology and Comprehensive Cancer Center, University of California, Davis, California, USA
Bruce D. Hammock
3Department of Entomology and Nematology and Comprehensive Cancer Center, University of California, Davis, California, USA
Santiago Vázquez
2Laboratori de Química Farmacèutica (Unitat Associada al CSIC), Department de Farmacologia, Toxicologia i Química Terapèutica, Facultat de Farmàcia i Ciències de l’Alimentació, and Institute of Biomedicine (IBUB), Universitat de Barcelona, Av. Joan XXIII, 27-31, E-08028 Barcelona, Spain
Mercè Pallàs
1Pharmacology Section. Department of Pharmacology, Toxicology and Medicinal Chemistry, Faculty of Pharmacy and Food Sciences, and Institut de Neurociències, University of Barcelona, Av. Joan XXIII, 27-31, E-08028 Barcelona, Spain
Carles Galdeano
7Department of Pharmacy and Pharmaceutical Technology and Physical Chemistry, Faculty of Pharmacy and Food Sciences and Institute of Biomedicine (IBUB), University of Barcelona, Av. Joan XXIII, 27-31, E-08028 Barcelona, Spain
Article usage
Posted April 10, 2019.
Pharmacological inhibition of soluble epoxide hydrolase as a new therapy for Alzheimer’s Disease
Christian Griñán-Ferré, Sandra Codony, Eugènia Pujol, Jun Yang, Rosana Leiva, Carmen Escolano, Dolors Puigoriol-Illamola, Júlia Companys-Alemany, Rubén Corpas, Coral Sanfeliu, M. Isabel Loza, José Brea, Christophe Morisseau, Bruce D. Hammock, Santiago Vázquez, Mercè Pallàs, Carles Galdeano
bioRxiv 605055; doi: https://doi.org/10.1101/605055
Pharmacological inhibition of soluble epoxide hydrolase as a new therapy for Alzheimer’s Disease
Christian Griñán-Ferré, Sandra Codony, Eugènia Pujol, Jun Yang, Rosana Leiva, Carmen Escolano, Dolors Puigoriol-Illamola, Júlia Companys-Alemany, Rubén Corpas, Coral Sanfeliu, M. Isabel Loza, José Brea, Christophe Morisseau, Bruce D. Hammock, Santiago Vázquez, Mercè Pallàs, Carles Galdeano
bioRxiv 605055; doi: https://doi.org/10.1101/605055
Subject Area
Subject Areas
- Biochemistry (11715)
- Bioengineering (8723)
- Bioinformatics (29129)
- Biophysics (14936)
- Cancer Biology (12049)
- Cell Biology (17359)
- Clinical Trials (138)
- Developmental Biology (9406)
- Ecology (14144)
- Epidemiology (2067)
- Evolutionary Biology (18268)
- Genetics (12221)
- Genomics (16767)
- Immunology (11843)
- Microbiology (28014)
- Molecular Biology (11560)
- Neuroscience (60814)
- Paleontology (450)
- Pathology (1864)
- Pharmacology and Toxicology (3231)
- Physiology (4940)
- Plant Biology (10384)
- Synthetic Biology (2878)
- Systems Biology (7333)
- Zoology (1642)